Patents by Inventor Ricky CAIN

Ricky CAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
    Publication number: 20250057816
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
    Type: Application
    Filed: October 22, 2024
    Publication date: February 20, 2025
    Inventors: Ferda Cevikbas, Ashley Jarvis, Laura Gleave, Nina Connelly Ursinyova, Ricky Cain, Wei Tsung Yau
  • ?-lactamase inhibitors
    Patent number: 11980631
    Abstract: The present invention relates to the use of certain ?-lactamase inhibitors in conjunction with one or more ?-lactam antibiotics for the treatment of Strenotrophomonas maltophilia, tuberculosis or Pseudomonas species infections.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: May 14, 2024
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Jürgen Brem, Christopher J. Schofield, Samuel T. Cahill, Karina Calvopina, Philip Hinchcliffe, Ricky Cain, James Spencer, Collin W. G. Fishwick, Matthew B. Avison
  • MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
    Publication number: 20230029266
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
    Type: Application
    Filed: November 5, 2020
    Publication date: January 26, 2023
    Inventors: Ferda Cevikbas, Ashley Jarvis, Laura Gleave, Nina Connelly Ursinyova, Ricky Cain, Wei Tsung Yau
  • ß-LACTAMASE INHIBITORS
    Publication number: 20210275552
    Abstract: The present invention relates to the use of certain ?-lactamase inhibitors in conjunction with one or more ?-lactam antibiotics for the treatment of Strenotrophomonas maltophilia, tuberculosis or Pseudomonas species infections.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 9, 2021
    Inventors: Jürgen BREM, Christopher J. SCHOFIELD, Samuel T. CAHILL, Karina CALVOPINA, Phillip HINCHCLIFFE, Ricky CAIN, James SPENCER, Collin W.G. FISHWICK, Mathew B. AVISON